NCT01110044View on ClinicalTrials.gov

Study of a Birth Dose of GlaxoSmithKline Biologicals' 251154 Vaccine

PHASE2WithdrawnINTERVENTIONAL

0

Timeline

Start Date

April 30, 2010

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions

Infections, Rotavirus

Interventions

BIOLOGICAL

251154 vaccine

Intramuscular, single dose

BIOLOGICAL

Infanrix hexa™

Intramuscular, four doses

BIOLOGICAL

Synflorix™

Intramuscular, four doses

BIOLOGICAL

Rotarix™

Oral, two doses

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY